Cervical Interlaminar Versus Transforaminal Epidural Steroid Injection
Primary Purpose
Cervical Radiculopathy
Status
Withdrawn
Phase
Phase 4
Locations
Study Type
Interventional
Intervention
Transforaminal Epidural Steroid Injection with Dexamethasone
Interlaminar Epidural Steroid Injection with Betamethasone
Sponsored by
About this trial
This is an interventional treatment trial for Cervical Radiculopathy
Eligibility Criteria
Inclusion Criteria:
- - aged >18, capable of understanding and providing consent in English, capable of complying with the outcome instruments used, capable of attending all planned follow up visits
- unilateral cervical radicular pain as defined by arm pain or shoulder girdle pain/periscapular pain with or without neck pain of at least 2 weeks.
- 7 day average of numeric pain rating score (NPRS) for arm pain or shoulder girdle/periscapular pain of at least 5/10 at baseline evaluation
- MRI (or CT if MRI not available) shows one or two level cervical disc herniation(s) or disc osteophyte complex(es) between levels C4-T1, corresponding in location with unilateral radicular pain, with or without neurological deficits. MRI or CT may show degenerative changes at other levels.
- Patient consents to treatment with epidural injection in a shared decision-making process with the treating physician.
- Pain duration of at least 2 weeks or more.
Exclusion Criteria:
- - Neck pain is greater than arm pain or shoulder girdle/periscapular pain based on 7 day average NPRS
- Those receiving remuneration for their pain treatment (e.g., disability, worker's compensation).
- Those involved in active litigation relevant to their pain.
- Those unable to read English and complete the assessment instruments.
- Those unable to attend follow up appointments
- The patient is incarcerated.
- Spondylolisthesis at the involved or adjacent segments.
- History of prior cervical surgery
- Progressive motor deficit, and/or clinical signs of myelopathy.
- Prior cervical epidural steroid injections.
- Prior epidural steroid injection within the prior 12 months in any location within the spine.
- Possible pregnancy or other reason that precludes the use of fluoroscopy.
- Allergy to contrast media or local anesthetics.
- BMI>35.
- Systemic inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis, lupus).
- Active infection or treatment of infection with antibiotics within the past 7 days.
- Medical conditions causing significant functional disability (e.g., stroke, COPD)
- Chronic widespread pain or somatoform disorder (e.g. fibromyalgia).
- Addictive behavior, severe clinical depression, or psychotic features.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
Tranforaminal
Interlaminar
Arm Description
will receive cervical epidural injection via a transforaminal route with dexamethasone steroid
will receive cervical epidural injection via an interlaminar route with betamethasone steroid
Outcomes
Primary Outcome Measures
Pain
Numeric rating pain score
Secondary Outcome Measures
Full Information
NCT ID
NCT03165825
First Posted
May 16, 2017
Last Updated
October 2, 2018
Sponsor
Vanderbilt University Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT03165825
Brief Title
Cervical Interlaminar Versus Transforaminal Epidural Steroid Injection
Official Title
Pragmatic Randomized Prospective Study of Cervical Interlaminar Epidural Injection of Particulate Steroid and Cervical Transforaminal Epidural Injection of Non-particulate Steroid in Patients With Cervical Radicular Pain
Study Type
Interventional
2. Study Status
Record Verification Date
October 2018
Overall Recruitment Status
Withdrawn
Why Stopped
funding
Study Start Date
January 2018 (Anticipated)
Primary Completion Date
September 2019 (Anticipated)
Study Completion Date
October 2019 (Anticipated)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Vanderbilt University Medical Center
4. Oversight
Studies a U.S. FDA-regulated Drug Product
Yes
Studies a U.S. FDA-regulated Device Product
No
Product Manufactured in and Exported from the U.S.
No
5. Study Description
Brief Summary
compare cervical interlaminar epidural injection of betamethasone (9mg) and cervical transforaminal epidural injection of dexamethasone (15 mg) for cervical radicular pain
Detailed Description
This study will compare one route of epidural steroid injection (interlaminar) using a particulate steroid to another route of epidural steroid injection (transforaminal) using a different non-particulate steroid dexamethasone. Repeat injections may be allowed.
All injections will be done with image guidance. Patients will be evaluated for improvements in pain and function.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cervical Radiculopathy
7. Study Design
Primary Purpose
Treatment
Study Phase
Phase 4
Interventional Study Model
Parallel Assignment
Masking
Participant
Allocation
Randomized
Enrollment
0 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Tranforaminal
Arm Type
Experimental
Arm Description
will receive cervical epidural injection via a transforaminal route with dexamethasone steroid
Arm Title
Interlaminar
Arm Type
Active Comparator
Arm Description
will receive cervical epidural injection via an interlaminar route with betamethasone steroid
Intervention Type
Drug
Intervention Name(s)
Transforaminal Epidural Steroid Injection with Dexamethasone
Other Intervention Name(s)
Decadron
Intervention Description
Transforaminal Epidural Steroid Injection with Dexamethasone
Intervention Type
Drug
Intervention Name(s)
Interlaminar Epidural Steroid Injection with Betamethasone
Intervention Description
Interlaminar Epidural Steroid Injection with Betamethasone
Primary Outcome Measure Information:
Title
Pain
Description
Numeric rating pain score
Time Frame
12 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
99 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
- aged >18, capable of understanding and providing consent in English, capable of complying with the outcome instruments used, capable of attending all planned follow up visits
unilateral cervical radicular pain as defined by arm pain or shoulder girdle pain/periscapular pain with or without neck pain of at least 2 weeks.
7 day average of numeric pain rating score (NPRS) for arm pain or shoulder girdle/periscapular pain of at least 5/10 at baseline evaluation
MRI (or CT if MRI not available) shows one or two level cervical disc herniation(s) or disc osteophyte complex(es) between levels C4-T1, corresponding in location with unilateral radicular pain, with or without neurological deficits. MRI or CT may show degenerative changes at other levels.
Patient consents to treatment with epidural injection in a shared decision-making process with the treating physician.
Pain duration of at least 2 weeks or more.
Exclusion Criteria:
- Neck pain is greater than arm pain or shoulder girdle/periscapular pain based on 7 day average NPRS
Those receiving remuneration for their pain treatment (e.g., disability, worker's compensation).
Those involved in active litigation relevant to their pain.
Those unable to read English and complete the assessment instruments.
Those unable to attend follow up appointments
The patient is incarcerated.
Spondylolisthesis at the involved or adjacent segments.
History of prior cervical surgery
Progressive motor deficit, and/or clinical signs of myelopathy.
Prior cervical epidural steroid injections.
Prior epidural steroid injection within the prior 12 months in any location within the spine.
Possible pregnancy or other reason that precludes the use of fluoroscopy.
Allergy to contrast media or local anesthetics.
BMI>35.
Systemic inflammatory arthritis (e.g., rheumatoid arthritis, ankylosing spondylitis, lupus).
Active infection or treatment of infection with antibiotics within the past 7 days.
Medical conditions causing significant functional disability (e.g., stroke, COPD)
Chronic widespread pain or somatoform disorder (e.g. fibromyalgia).
Addictive behavior, severe clinical depression, or psychotic features.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Byron Schneider
Organizational Affiliation
Assistant professor
Official's Role
Principal Investigator
12. IPD Sharing Statement
Plan to Share IPD
No
Learn more about this trial
Cervical Interlaminar Versus Transforaminal Epidural Steroid Injection
We'll reach out to this number within 24 hrs